Skip to main content
Erschienen in: Reviews in Endocrine and Metabolic Disorders 3/2020

16.05.2020

Acute assessment of subjective appetite and implicated hormones after a hypnosis-induced hallucinated meal: a randomized cross-over pilot trial

verfasst von: Iolanda Cioffi, Roberto Gambino, Rosalba Rosato, Bice Properzi, Giuseppe Regaldo, Valentina Ponzo, Marianna Pellegrini, Franco Contaldo, Fabrizio Pasanisi, Ezio Ghigo, Simona Bo

Erschienen in: Reviews in Endocrine and Metabolic Disorders | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

The use of hypnosis can generate hallucinatory phenomena, which ranged from vivid/auditory imagery to fully developed “hallucinations” in selected people. The aim of this pilot trial was investigating the acute effects of a hypnosis-induced hallucinated breakfast (HB) compared to those of a real breakfast (RB) on subjective appetite and appetite-regulating hormones in highly hypnotizable individuals. Eight healthy post-menopausal women were recruited to consume two meals: the HB and the RB in a randomized crossover design. Participants underwent appetite sensations measurements (before meal and each 30-min until 270-min) and blood sample collection (at 0, 20, 60, 90, 180-min). A 3-day food-record was filled after each meal. The adjusted repeated measures ANCOVA did not show any meal×time interactions on subjective appetite postprandially. As expected, significantly higher glucose (p < 0.001), insulin (p < 0.001), and lower free fatty acid (p < 0.001) concentrations were found after the RB, but not following HB. Furthermore, RB significantly increased postprandial levels of glucagon-like-peptide-1 and peptide-YY at 20, 60, 90 and 180-min, whereas acylated-ghrelin and leptin levels did not differ. Postprandial neuropeptide-Y and orexin-A values significantly increased at different time-points after RB, but not following HB, while α-melanocyte-stimulating hormone levels enhanced after HB only. Energy intakes were significantly lower after HB on the test-day only (HB = 1146.6 ± 343.8 vs RB = 1634.7 ± 274.2 kcal/d; p = 0.003). Appetite sensation might be modulated by fully developed meal “hallucination” induced by hypnosis, likely affecting brain-peptides implicated in the appetite regulation. However, further studies are needed to verify these results obtained in a highly selected group of individuals. NCT03934580.
Literatur
1.
Zurück zum Zitat Hopkins M, Blundell J, Halford J, King N, Finlayson G. The regulation of food intake in humans. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, et al., editors. Endotext [internet]. South Dartmouth: MDText.com, Inc.; 2000. Hopkins M, Blundell J, Halford J, King N, Finlayson G. The regulation of food intake in humans. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, et al., editors. Endotext [internet]. South Dartmouth: MDText.com, Inc.; 2000.
2.
Zurück zum Zitat Blundell J, de Graaf C, Hulshof T, Jebb S, Livingstone B, Lluch A, Mela D, Salah S, Schuring E, van der Knaap H, Westerterp M. Appetite control: methodological aspects of the evaluation of foods. Obes Rev. 2010;11:251–70.PubMedPubMedCentral Blundell J, de Graaf C, Hulshof T, Jebb S, Livingstone B, Lluch A, Mela D, Salah S, Schuring E, van der Knaap H, Westerterp M. Appetite control: methodological aspects of the evaluation of foods. Obes Rev. 2010;11:251–70.PubMedPubMedCentral
3.
Zurück zum Zitat Halford JC, Blundell JE. Separate systems for serotonin and leptin in appetite control. Ann Med. 2000;32:222–32.PubMed Halford JC, Blundell JE. Separate systems for serotonin and leptin in appetite control. Ann Med. 2000;32:222–32.PubMed
4.
Zurück zum Zitat Zanchi D, Depoorter A, Egloff L, Haller S, Mählmann L, Lang UE, Drewe J, Beglinger C, Schmidt A, Borgwardt S. The impact of gut hormones on the neural circuit of appetite and satiety: a systematic review. Neurosci Biobehav Rev. 2017;80:457–75.PubMed Zanchi D, Depoorter A, Egloff L, Haller S, Mählmann L, Lang UE, Drewe J, Beglinger C, Schmidt A, Borgwardt S. The impact of gut hormones on the neural circuit of appetite and satiety: a systematic review. Neurosci Biobehav Rev. 2017;80:457–75.PubMed
5.
Zurück zum Zitat Coll AP. Effects of pro-opiomelanocortin (POMC) on food intake and body weight: mechanisms and therapeutic potential? Clin Sci. 2007;113:171–82. Coll AP. Effects of pro-opiomelanocortin (POMC) on food intake and body weight: mechanisms and therapeutic potential? Clin Sci. 2007;113:171–82.
6.
Zurück zum Zitat Williams DL. Neural integration of satiation and food reward: role of GLP-1 and orexin pathways. Physiol Behav. 2014;136:194–9.PubMedPubMedCentral Williams DL. Neural integration of satiation and food reward: role of GLP-1 and orexin pathways. Physiol Behav. 2014;136:194–9.PubMedPubMedCentral
7.
Zurück zum Zitat Yeomans MR, Blundell JE, Leshem M. Palatability: response to nutritional need or need-free stimulation of appetite? Br J Nutr. 2004;(Suppl 1):S3–14. Yeomans MR, Blundell JE, Leshem M. Palatability: response to nutritional need or need-free stimulation of appetite? Br J Nutr. 2004;(Suppl 1):S3–14.
8.
Zurück zum Zitat Gumbs MCR, van den Heuvel JK, la Fleur SE. The effect of obesogenic diets on brain Neuropeptide Y. Physiol Behav. 2016;162:161–73.PubMed Gumbs MCR, van den Heuvel JK, la Fleur SE. The effect of obesogenic diets on brain Neuropeptide Y. Physiol Behav. 2016;162:161–73.PubMed
9.
Zurück zum Zitat Steinert RE, Feinle-Bisset C, Asarian L, Horowitz M, Beglinger C, Ghrelin GN. CCK, GLP-1, and PYY(3-36): secretory controls and physiological roles in eating and Glycemia in health, obesity, and after RYGB. Physiol Rev. 2017;97:411–63.PubMed Steinert RE, Feinle-Bisset C, Asarian L, Horowitz M, Beglinger C, Ghrelin GN. CCK, GLP-1, and PYY(3-36): secretory controls and physiological roles in eating and Glycemia in health, obesity, and after RYGB. Physiol Rev. 2017;97:411–63.PubMed
10.
Zurück zum Zitat Kirsch I. Hypnotic enhancement of cognitive-behavioral weight loss treatments--another meta-reanalysis. J Consult Clin Psychol. 1996;64:517–9.PubMed Kirsch I. Hypnotic enhancement of cognitive-behavioral weight loss treatments--another meta-reanalysis. J Consult Clin Psychol. 1996;64:517–9.PubMed
11.
Zurück zum Zitat Pittler MH, Ernst E. Complementary therapies for reducing body weight: a systematic review. Int J Obes. 2005;29:1030–8. Pittler MH, Ernst E. Complementary therapies for reducing body weight: a systematic review. Int J Obes. 2005;29:1030–8.
12.
Zurück zum Zitat Bo S, Rahimi F, Goitre I, Properzi B, Ponzo V, Regaldo G, Boschetti S, Fadda M, Ciccone G, Abbate Daga G, Mengozzi G, Evangelista A, de Francesco A, Belcastro S, Broglio F. Effects of self-conditioning techniques (self-hypnosis) in promoting weight loss in patients with severe obesity: a randomized controlled trial. Obesity. 2018;26:1422–9.PubMed Bo S, Rahimi F, Goitre I, Properzi B, Ponzo V, Regaldo G, Boschetti S, Fadda M, Ciccone G, Abbate Daga G, Mengozzi G, Evangelista A, de Francesco A, Belcastro S, Broglio F. Effects of self-conditioning techniques (self-hypnosis) in promoting weight loss in patients with severe obesity: a randomized controlled trial. Obesity. 2018;26:1422–9.PubMed
13.
Zurück zum Zitat Entwistle PA, Webb RJ, Abayomi JC, Johnson B, Sparkes AC, Davies IG. Unconscious agendas in the etiology of refractory obesity and the role of hypnosis in their identification and resolution: a new paradigm for weight-management programs or a paradigm revisited? Int J Clin Exp Hypn. 2014;62:330–59.PubMed Entwistle PA, Webb RJ, Abayomi JC, Johnson B, Sparkes AC, Davies IG. Unconscious agendas in the etiology of refractory obesity and the role of hypnosis in their identification and resolution: a new paradigm for weight-management programs or a paradigm revisited? Int J Clin Exp Hypn. 2014;62:330–59.PubMed
14.
Zurück zum Zitat Chiarioni G, Vantini I, De Iorio F, Benini L. Prokinetic effect of gut-oriented hypnosis on gastric emptying. Aliment Pharmacol Ther. 2006;23:1241–9.PubMed Chiarioni G, Vantini I, De Iorio F, Benini L. Prokinetic effect of gut-oriented hypnosis on gastric emptying. Aliment Pharmacol Ther. 2006;23:1241–9.PubMed
15.
Zurück zum Zitat Klein KB, Spiegel D. Modulation of gastric acid secretion by hypnosis. Gastroenterology. 1989;96:1383–7.PubMed Klein KB, Spiegel D. Modulation of gastric acid secretion by hypnosis. Gastroenterology. 1989;96:1383–7.PubMed
16.
Zurück zum Zitat Lea R, Houghton LA, Calvert EL, Larder S, Gonsalkorale WM, Whelan V, Randles J, Cooper P, Cruickshanks P, Miller V, Whorwell PJ. Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2003;17:635–42.PubMed Lea R, Houghton LA, Calvert EL, Larder S, Gonsalkorale WM, Whelan V, Randles J, Cooper P, Cruickshanks P, Miller V, Whorwell PJ. Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2003;17:635–42.PubMed
17.
Zurück zum Zitat Whorwell PJ, Prior A, Faragher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet. 1984;2:1232–4.PubMed Whorwell PJ, Prior A, Faragher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet. 1984;2:1232–4.PubMed
18.
Zurück zum Zitat Enck P, Hefner J, Herbert BM, Mazurak N, Weimer K, Muth ER, et al. Sensitivity and specificity of hypnosis effects on gastric myoelectrical activity. Gray M, editor. PLoS ONE. 2013;8:e83486.PubMedPubMedCentral Enck P, Hefner J, Herbert BM, Mazurak N, Weimer K, Muth ER, et al. Sensitivity and specificity of hypnosis effects on gastric myoelectrical activity. Gray M, editor. PLoS ONE. 2013;8:e83486.PubMedPubMedCentral
19.
Zurück zum Zitat Siddi S, Ochoa S, Laroi F, Cella M, Raballo A, Saldivia S, Quijada Y, Laloyaux J, Rocha NB, Lincoln TM, Schlier B, Ntouros E, Bozikas VP, Gawęda Ł, Machado S, Nardi AE, Rodante D, Deshpande SN, Haro JM, Preti A. A cross-national investigation of hallucination-like experiences in 10 countries: the E-CLECTIC study. Schizophr Bull. 2019;45:S43–S55.PubMedPubMedCentral Siddi S, Ochoa S, Laroi F, Cella M, Raballo A, Saldivia S, Quijada Y, Laloyaux J, Rocha NB, Lincoln TM, Schlier B, Ntouros E, Bozikas VP, Gawęda Ł, Machado S, Nardi AE, Rodante D, Deshpande SN, Haro JM, Preti A. A cross-national investigation of hallucination-like experiences in 10 countries: the E-CLECTIC study. Schizophr Bull. 2019;45:S43–S55.PubMedPubMedCentral
20.
Zurück zum Zitat Giuseppe Regaldo. Manuale di ipnosi medica rapida. 2014. Giuseppe Regaldo. Manuale di ipnosi medica rapida. 2014.
21.
Zurück zum Zitat Shor RE, Orne EC. Norms on the Harvard group scale of hypnotic susceptibility, form a. Int J Clin Exp Hypn. 1963;11:39–47.PubMed Shor RE, Orne EC. Norms on the Harvard group scale of hypnotic susceptibility, form a. Int J Clin Exp Hypn. 1963;11:39–47.PubMed
22.
Zurück zum Zitat Bowers KS. Waterloo-Stanford group scale of hypnotic susceptibility, form C: manual and response booklet. Int J Clin Exp Hypn. 1998;46:250–68.PubMed Bowers KS. Waterloo-Stanford group scale of hypnotic susceptibility, form C: manual and response booklet. Int J Clin Exp Hypn. 1998;46:250–68.PubMed
23.
Zurück zum Zitat Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord. 2000;24:38–48.PubMed Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord. 2000;24:38–48.PubMed
24.
Zurück zum Zitat Katschinski M, Dahmen G, Reinshagen M, Beglinger C, Koop H, Nustede R, Adler G. Cephalic stimulation of gastrointestinal secretory and motor responses in humans. Gastroenterology. 1992;103:383–91.PubMed Katschinski M, Dahmen G, Reinshagen M, Beglinger C, Koop H, Nustede R, Adler G. Cephalic stimulation of gastrointestinal secretory and motor responses in humans. Gastroenterology. 1992;103:383–91.PubMed
25.
Zurück zum Zitat Spiegel D. Negative and positive visual hypnotic hallucinations: attending inside and out. Int J Clin Exp Hypn. 2003;51:130–46.PubMed Spiegel D. Negative and positive visual hypnotic hallucinations: attending inside and out. Int J Clin Exp Hypn. 2003;51:130–46.PubMed
26.
Zurück zum Zitat Ferrario CR, Labouèbe G, Liu S, Nieh EH, Routh VH, Xu S, O'Connor EC. Homeostasis meets motivation in the battle to control food intake. J Neurosci. 2016;36:11469–81.PubMedPubMedCentral Ferrario CR, Labouèbe G, Liu S, Nieh EH, Routh VH, Xu S, O'Connor EC. Homeostasis meets motivation in the battle to control food intake. J Neurosci. 2016;36:11469–81.PubMedPubMedCentral
27.
Zurück zum Zitat Sakurai T. Roles of orexins in the regulation of body weight homeostasis. Obes Res Clin Pract. 2014;8:e414–20.PubMed Sakurai T. Roles of orexins in the regulation of body weight homeostasis. Obes Res Clin Pract. 2014;8:e414–20.PubMed
28.
Zurück zum Zitat Morello G, Imperatore R, Palomba L, Finelli C, Labruna G, Pasanisi F, Sacchetti L, Buono L, Piscitelli F, Orlando P, di Marzo V, Cristino L. Orexin-a represses satiety-inducing POMC neurons and contributes to obesity via stimulation of endocannabinoid signaling. Proc Natl Acad Sci U S A. 2016;113:4759–64.PubMedPubMedCentral Morello G, Imperatore R, Palomba L, Finelli C, Labruna G, Pasanisi F, Sacchetti L, Buono L, Piscitelli F, Orlando P, di Marzo V, Cristino L. Orexin-a represses satiety-inducing POMC neurons and contributes to obesity via stimulation of endocannabinoid signaling. Proc Natl Acad Sci U S A. 2016;113:4759–64.PubMedPubMedCentral
29.
Zurück zum Zitat Imperatore R, Palomba L, Cristino L. Role of Orexin-a in hypertension and obesity. Curr Hypertens Rep. 2017;19:34.PubMed Imperatore R, Palomba L, Cristino L. Role of Orexin-a in hypertension and obesity. Curr Hypertens Rep. 2017;19:34.PubMed
30.
Zurück zum Zitat Goforth PB, Myers MG. Roles for Orexin/Hypocretin in the control of energy balance and metabolism. Curr Top Behav Neurosci. 2017;33:137–56.PubMed Goforth PB, Myers MG. Roles for Orexin/Hypocretin in the control of energy balance and metabolism. Curr Top Behav Neurosci. 2017;33:137–56.PubMed
31.
Zurück zum Zitat Nixon JP, Kotz CM, Novak CM, Billington CJ, Teske JA. Neuropeptides controlling energy balance: Orexins and Neuromedins. In: Joost H-G, editor. Appetite control. Berlin: Springer. p. 2012, 77–109. Nixon JP, Kotz CM, Novak CM, Billington CJ, Teske JA. Neuropeptides controlling energy balance: Orexins and Neuromedins. In: Joost H-G, editor. Appetite control. Berlin: Springer. p. 2012, 77–109.
32.
Zurück zum Zitat Yi M, Li H, Wu Z, Yan J, Liu Q, Ou C, Chen M. A promising therapeutic target for metabolic diseases: neuropeptide Y receptors in humans. Cell Physiol Biochem. 2018;45:88–107.PubMed Yi M, Li H, Wu Z, Yan J, Liu Q, Ou C, Chen M. A promising therapeutic target for metabolic diseases: neuropeptide Y receptors in humans. Cell Physiol Biochem. 2018;45:88–107.PubMed
33.
Zurück zum Zitat Muroi Y, Ishii T. A novel neuropeptide Y neuronal pathway linking energy state and reproductive behavior. Neuropeptides. 2016;59:1–8.PubMed Muroi Y, Ishii T. A novel neuropeptide Y neuronal pathway linking energy state and reproductive behavior. Neuropeptides. 2016;59:1–8.PubMed
34.
Zurück zum Zitat Mercer RE, Chee MJS, Colmers WF. The role of NPY in hypothalamic mediated food intake. Front Neuroendocrinol. 2011;32:398–415.PubMed Mercer RE, Chee MJS, Colmers WF. The role of NPY in hypothalamic mediated food intake. Front Neuroendocrinol. 2011;32:398–415.PubMed
35.
Zurück zum Zitat Holst JJ. Incretin hormones and the satiation signal. Int J Obes. 2013;37:1161–8. Holst JJ. Incretin hormones and the satiation signal. Int J Obes. 2013;37:1161–8.
36.
Zurück zum Zitat van Bloemendaal L, Ten Kulve JS, la Fleur SE, Ijzerman RG, Diamant M. Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS. J Endocrinol. 2014;221:T1–16.PubMed van Bloemendaal L, Ten Kulve JS, la Fleur SE, Ijzerman RG, Diamant M. Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS. J Endocrinol. 2014;221:T1–16.PubMed
37.
Zurück zum Zitat Stadlbauer U, Woods SC, Langhans W, Meyer U. PYY3-36: beyond food intake. Front Neuroendocrinol. 2015;38:1–11.PubMed Stadlbauer U, Woods SC, Langhans W, Meyer U. PYY3-36: beyond food intake. Front Neuroendocrinol. 2015;38:1–11.PubMed
38.
Zurück zum Zitat Gibbons C, Caudwell P, Finlayson G, Webb D-L, Hellström PM, Näslund E, Blundell JE. Comparison of postprandial profiles of ghrelin, active GLP-1, and Total PYY to meals varying in fat and carbohydrate and their association with hunger and the phases of satiety. J Clin Endocrinol Metab. 2013;98:E847–55.PubMed Gibbons C, Caudwell P, Finlayson G, Webb D-L, Hellström PM, Näslund E, Blundell JE. Comparison of postprandial profiles of ghrelin, active GLP-1, and Total PYY to meals varying in fat and carbohydrate and their association with hunger and the phases of satiety. J Clin Endocrinol Metab. 2013;98:E847–55.PubMed
39.
Zurück zum Zitat Broglio F, Arvat E, Benso A, Gottero C, Prodam F, Granata R, Papotti M, Muccioli G, Deghenghi R, Ghigo E. Ghrelin: much more than a natural growth hormone secretagogue. Isr Med Assoc J. 2002;4:607–13.PubMed Broglio F, Arvat E, Benso A, Gottero C, Prodam F, Granata R, Papotti M, Muccioli G, Deghenghi R, Ghigo E. Ghrelin: much more than a natural growth hormone secretagogue. Isr Med Assoc J. 2002;4:607–13.PubMed
40.
Zurück zum Zitat Harris RBS. Direct and indirect effects of leptin on adipocyte metabolism. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2014;1842:414–23. Harris RBS. Direct and indirect effects of leptin on adipocyte metabolism. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2014;1842:414–23.
41.
42.
Zurück zum Zitat Oswal A, Yeo G. Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity. Obesity. 2010;18:221–9.PubMed Oswal A, Yeo G. Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity. Obesity. 2010;18:221–9.PubMed
43.
Zurück zum Zitat Cristino L, Busetto G, Imperatore R, Ferrandino I, Palomba L, Silvestri C, Petrosino S, Orlando P, Bentivoglio M, Mackie K, di Marzo V. Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons. Proc Natl Acad Sci. 2013;110:E2229–38.PubMedPubMedCentral Cristino L, Busetto G, Imperatore R, Ferrandino I, Palomba L, Silvestri C, Petrosino S, Orlando P, Bentivoglio M, Mackie K, di Marzo V. Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons. Proc Natl Acad Sci. 2013;110:E2229–38.PubMedPubMedCentral
44.
Zurück zum Zitat Yeo GSH. Genetics of obesity: can an old dog teach us new tricks? Diabetologia. 2017;60(5):778–83.PubMed Yeo GSH. Genetics of obesity: can an old dog teach us new tricks? Diabetologia. 2017;60(5):778–83.PubMed
45.
Zurück zum Zitat Zhu P, Sun W, Zhang C, Song Z, Lin S. The role of neuropeptide Y in the pathophysiology of atherosclerotic cardiovascular disease. Int J Cardiol. 2016;220:235–41.PubMed Zhu P, Sun W, Zhang C, Song Z, Lin S. The role of neuropeptide Y in the pathophysiology of atherosclerotic cardiovascular disease. Int J Cardiol. 2016;220:235–41.PubMed
46.
Zurück zum Zitat Cintron D, Beckman JP, Bailey KR, Lahr BD, Jayachandran M, Miller VM. Plasma orexin a levels in recently menopausal women during and 3 years following use of hormone therapy. Maturitas. 2017;99:59–65.PubMedPubMedCentral Cintron D, Beckman JP, Bailey KR, Lahr BD, Jayachandran M, Miller VM. Plasma orexin a levels in recently menopausal women during and 3 years following use of hormone therapy. Maturitas. 2017;99:59–65.PubMedPubMedCentral
47.
Zurück zum Zitat Jiang H, White MP, Greicius MD, Waelde LC, Spiegel D. Brain activity and functional connectivity associated with hypnosis. Cereb Cortex. 2017;27:4083–93.PubMed Jiang H, White MP, Greicius MD, Waelde LC, Spiegel D. Brain activity and functional connectivity associated with hypnosis. Cereb Cortex. 2017;27:4083–93.PubMed
Metadaten
Titel
Acute assessment of subjective appetite and implicated hormones after a hypnosis-induced hallucinated meal: a randomized cross-over pilot trial
verfasst von
Iolanda Cioffi
Roberto Gambino
Rosalba Rosato
Bice Properzi
Giuseppe Regaldo
Valentina Ponzo
Marianna Pellegrini
Franco Contaldo
Fabrizio Pasanisi
Ezio Ghigo
Simona Bo
Publikationsdatum
16.05.2020
Verlag
Springer US
Erschienen in
Reviews in Endocrine and Metabolic Disorders / Ausgabe 3/2020
Print ISSN: 1389-9155
Elektronische ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-020-09559-4

Weitere Artikel der Ausgabe 3/2020

Reviews in Endocrine and Metabolic Disorders 3/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.